As of June 1, 2017, the below number of cases have been recruited in Swedegene. DNA and clinical data collection for these cases are completed.
|ADR type||Number of cases|
|Angioedema (mainly related to ACE-inhibitors/ARBs)||479|
|Cough related to ACE-inhibitors||151|
|Osteonecrosis and atypical fractures due to bisphosphonates||107|
|Phototoxic reactions (mainly due to topical NSAIDs)||48|
|Drug hypersensitivity, mainly antibiotics and NSAIDs||313|
|Metabolic reactions from neuroleptics and antidepressants (mainly weight gain)||46|
|Hyponatremia/SIADH due to antidepressants and antiepileptics||36|
|CNS toxicity and neuropsychiatric reactions from antiviral therapy and antibiotics||80|
|Stevens-Johnson syndrome/Toxic epidermal necrolysis||58|
|Tendon-rupture from flouroquinolones||24|
|Rhabdomyolysis related to statins/fibrates||48|
|Torsade de Pointes/QT-prolongation||17|
|Agranulocytosis and neutropenia from non-chemotherapeutic agents||172|
|Narcolepsy associated with Pandemrix||64|
|Ototoxicity and vestibular toxicity||6|
|Bleedings from new oral anticoagulants (NOACs)||52|
|Other blood cell dyscrasia||15|
|Total number of cases||2529|
ACE = angiotensin converting enzyme; ARB = angiotensin II type 1 receptor blocker; NSAID = non-steroidal anti-inflammatory drug.
Note that the number of cases for a particular ADR may be greater than the total number of cases as some individuals have experienced multiple ADRs concomitantly.